This guide covers what causes PIH, why the type of pigmentation determines your treatment approach, which therapies work best and in what order, and the common mistakes that make dark spots worse.
TLDR
- PIH is excess melanin deposited after inflammation heals—it's not a scar, and it responds to targeted treatment
- Epidermal PIH (brown) fades in 6–12 months with topicals; dermal PIH (blue-gray) may be permanent
- Combine a tyrosinase inhibitor, retinoid, and daily SPF 30+ sunscreen as your first-line treatment approach
- UV exposure is the single biggest factor that worsens PIH—protection is non-negotiable
- Address the underlying inflammatory condition (acne, eczema) before starting any lightening therapy
What Is Post-Inflammatory Hyperpigmentation and Why Does It Happen?
Post-inflammatory hyperpigmentation is excess pigmentation that develops at the site of healed skin injury or inflammation. It occurs when melanocytes—the cells that produce skin pigment—overproduce melanin in response to inflammatory signals. Unlike scarring, which involves changes to skin texture and structure, PIH is purely a pigmentation response.
The Biological Trigger
When your skin experiences inflammation from acne, eczema, or injury, your immune system releases inflammatory mediators — including interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and reactive oxygen species — documented in dermatological research. These signals stimulate melanocytes to produce excess melanin, which is then transferred to surrounding skin cells, causing visible darkening.
The more intense or prolonged the inflammation, the deeper and more persistent the pigmentation becomes.
Common Causes of PIH
Frequent triggers include:
- Acne vulgaris — the most common cause, with 87% of Middle Eastern patients with acne developing PIH
- Atopic dermatitis (eczema)
- Insect bites and allergic reactions
- Contact dermatitis
- Burns (thermal, chemical, or laser-induced)
- Psoriasis and other inflammatory skin conditions
- Dermatological procedures such as chemical peels and laser treatments
PIH affects all skin tones, but it is more common and more severe in people with Fitzpatrick skin types IV–VI. One large study found that 65% of African American patients with acne developed PIH, compared to 25% of Caucasian patients — a gap that underscores how skin tone shapes both risk and treatment priorities.
Epidermal vs. Dermal PIH: Why the Difference Changes Your Treatment Plan
Not all PIH responds to treatment the same way. Whether pigment has settled in the upper skin layers or deeper dermis shapes every decision: which treatments to use, how long to commit, and what outcomes to realistically expect.
Epidermal PIH
Melanin is deposited within the upper skin layers (epidermis), appearing as tan, brown, or dark brown patches. This type responds well to topical treatments because the pigment is accessible to surface therapies. With consistent care, epidermal PIH typically improves within 6–12 months.
Dermal PIH
Results from severe or prolonged inflammation where melanin escapes into the deeper dermis and is engulfed by immune cells called macrophages. This creates a blue-gray or gray-brown hue that is much harder to treat. Dermal PIH may be permanent or take years to fade because the pigment sits beyond the reach of most topical agents.
How to Tell the Difference
Color is your first clue:
- Brown or dark brown = likely epidermal
- Blue-gray or gray-brown = likely dermal
A dermatologist can confirm the diagnosis using a Wood's lamp (UV light that makes epidermal pigment more visible) or, in unclear cases, a skin biopsy. Once you know which type you're dealing with, you can match your treatment approach to what the skin can actually respond to.
How to Treat Post-Inflammatory Hyperpigmentation
Step 1: Treat the Underlying Skin Condition First
PIH cannot be effectively resolved if the trigger inflammation is still active—new pigment will continue to form. Treating the source (acne, eczema, contact dermatitis) is the essential first step. Without controlling the underlying condition, any lightening treatment will produce temporary results at best.
Topical Agents: First-Line Treatment for PIH
Topical therapies are the primary treatment for PIH, particularly for epidermal pigmentation.
Tyrosinase Inhibitors
Hydroquinone remains the most studied and widely used topical lightening agent. Available at 2% over-the-counter and up to 4% by prescription, it works by blocking melanin production at the enzymatic level. A common clinical approach is the triple-combination formula (hydroquinone + tretinoin + low-potency steroid), which combines melanin suppression, accelerated cell turnover, and inflammation control.
In a 2024 randomized controlled trial, stabilized cysteamine 5% cream achieved efficacy parity with hydroquinone 4%/ascorbic acid 3% for acne-induced PIH at 4 months, offering a viable alternative for patients who prefer to avoid hydroquinone.
Supporting Topical Agents
Effective combination therapies include:
- Retinoids (tretinoin, adapalene): Accelerate cell turnover and disperse melanin. A 40-week study in Black patients showed significant PIH lightening with 0.1% tretinoin
- Azelaic acid: Offers dual benefit for acne and PIH by inhibiting tyrosinase and reducing inflammation
- Vitamin C (ascorbic acid): Acts as an antioxidant to interrupt melanin synthesis
- Niacinamide: Reduces melanosome transfer to skin cells and provides anti-inflammatory benefits
- Kojic acid and arbutin: Inhibit tyrosinase, though clinical data specific to PIH is limited
Combination therapy is typically more effective than any single agent alone. In practice, most patients see initial improvement within 4–8 weeks, with significant results at 3–6 months.
Procedures for Stubborn or Deeper PIH
When topical treatments plateau or PIH is primarily dermal, procedural interventions may be necessary.
Chemical Peels
Glycolic acid and salicylic acid peels work by removing melanin-containing epidermal cells. They can accelerate results for epidermal PIH that hasn't responded to topicals alone. However, they must be administered carefully—especially in darker skin tones—because irritation can paradoxically worsen PIH. A 22-week study found that adding glycolic acid peels to topical therapy showed a trend toward faster improvement.
Laser and Light-Based Therapies
Q-switched Nd:YAG and picosecond lasers target pigment at deeper levels and can be effective for refractory cases. However, these procedures carry an 11–17% risk of inducing new PIH in darker skin tones, making clinician experience and proper device settings critical.
Red Light Therapy (660nm)
Red light therapy at 660nm wavelength offers a complementary, non-invasive approach by reducing the inflammatory response that triggers PIH. Clinical trials demonstrate that 660nm photobiomodulation decreases pro-inflammatory cytokines like TNF-α and IL-1α, potentially minimizing the intensity of the initial inflammatory cascade.
For at-home use, the Lumara Systems 660nm red light therapy panel delivers 5-minute sessions at the precise wavelength used in clinical studies, making it a practical option for integrating photobiomodulation into a daily skincare routine.
Sun Protection: The Treatment Step Most People Skip
Daily broad-spectrum SPF 30 or higher sunscreen is essential during PIH treatment—skip it, and UV exposure will undo months of progress. UV exposure directly stimulates melanocytes and will deepen existing pigmentation, undoing months of progress. This applies regardless of skin tone—even deeply pigmented skin is vulnerable to UV-induced darkening of PIH.
The Perception Gap
Despite the critical role of photoprotection, significant behavioral gaps exist. A 2024 survey found that only 20.5% of African American respondents used sunscreen regularly, compared to 43.5% of white respondents. Even more concerning, 80% of African American respondents did not link sun exposure to hyperpigmentation.
Practical Sun Protection Habits
Beyond sunscreen:
- Wear protective clothing, wide-brimmed hats, and sunglasses
- Minimize peak-hour sun exposure (10 AM–4 PM)
- Choose tinted sunscreens containing iron oxide, which protect against visible light-induced pigmentation
- Reapply every 2 hours during extended outdoor exposure
These habits are backed by measurable data: a 2025 clinical trial found that broad-spectrum sunscreen with anti-inflammatory agents prevented nearly 16 ITA° units of darkening compared to unprotected skin—concrete proof that photoprotection actively stops PIH from forming.
What Makes Post-Inflammatory Hyperpigmentation Worse
UV Exposure Without Protection
Unprotected sun exposure is the single most powerful worsening factor. UV radiation stimulates melanocytes directly, deepening existing dark spots and prolonging resolution by months or years.
Picking, Scratching, or Irritating Active Lesions
Mechanical trauma intensifies inflammation and deepens melanin deposition. In a survey of 262 Middle Eastern patients with acne-induced PIH, 69% reported picking or scratching their lesions— and those patients consistently showed longer healing timelines.
Overly Aggressive Skincare
Introducing high-concentration actives too quickly, using harsh scrubs, or layering multiple exfoliants creates new inflammatory triggers. For example, combining a high-strength retinol with a glycolic acid toner in the same routine is a common way to trigger a flare that undoes weeks of fading progress.
Certain Medications
Some medications can darken post-inflammatory pigmentation or mimic PIH:
- Antimalarials (hydroxychloroquine): 26.3% incidence of drug-induced pigmentation
- Tetracyclines (minocycline): 3–15% incidence, with Type I pigmentation appearing specifically at sites of previous inflammation
- Anticancer agents: 17.7% of patients develop pigmentary changes
If you're taking any of these medications and PIH is a concern, discuss alternatives with your prescribing physician.
Frequently Asked Questions
What is the fastest treatment for post-inflammatory hyperpigmentation?
Combination topical therapy — a tyrosinase inhibitor (hydroquinone or cysteamine) plus a retinoid — with strict daily sun protection typically delivers visible improvement in epidermal PIH within 3–6 months. Dermal PIH takes longer regardless of approach; supervised chemical peels may help in resistant cases.
How long does post-inflammatory hyperpigmentation take to fade?
Epidermal PIH typically improves within 6–12 months with consistent treatment; left untreated, it can take years. Dermal PIH may take several years or never fully resolve, which is why starting treatment early matters.
Does post-inflammatory hyperpigmentation ever go away?
Epidermal PIH usually resolves over time, with treatment speeding up the process considerably. Dermal PIH can be permanent — preventing severe inflammation in the first place is the most reliable way to avoid it.
What is the gold standard treatment for post-inflammatory hyperpigmentation?
Combination therapy—typically a topical tyrosinase inhibitor (such as hydroquinone or cysteamine), a retinoid, and daily SPF 30+ sunscreen—is the established first-line approach. Procedures are reserved for cases that don't respond adequately to topicals.
What is the best product for post-inflammatory hyperpigmentation?
Effectiveness depends on PIH depth, skin type, and the underlying cause, so no single product works for everyone. Hydroquinone is the most clinically validated topical; azelaic acid, retinoids, and vitamin C are solid alternatives for different skin sensitivities.
What worsens post-inflammatory hyperpigmentation?
Unprotected sun exposure is the primary culprit, followed by picking or irritating active lesions, using overly harsh or irritating skincare products, and failing to treat the underlying inflammatory skin condition that generates new PIH.
